Efficacy and safety of once-daily roflumilast cream 0.3% in patients with knee/elbow involvement: Pooled results from phase 3 trials (DERMIS-1 and DERMIS-2)

被引：0
|
作者：
Ferris, Laura K. [1 ]
Draelos, Zoe D. [2 ]
Hebert, Adelaide A. [3 ]
Lynde, Charles W. [4 ]
Pariser, David M. [5 ,6 ]
Papp, Kim A. [7 ,8 ]
Yamauchi, Paul S. [9 ,10 ]
Feng, Amy [11 ]
Higham, Robert C. [11 ]
Burnett, Patrick [11 ]
Berk, David R. [11 ]
机构：
[1] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA
[2] Dermatol Consulting Serv, High Point, NC USA
[3] UT Hlth McGovern Med Sch, Houston, TX USA
[4] Lynderm Res Inc, Markham, ON, Canada
[5] Eastern Virginia Med Sch, Norfolk, VA USA
[6] Virginia Clin Res Inc, Norfolk, VA USA
[7] Prob Med Res, Waterloo, ON, Canada
[8] K Papp Clin Res, Waterloo, ON, Canada
[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[10] Dermatol Inst & Skin Care Ctr Inc, Santa Monica, CA USA
[11] Arcutis Biotherapeut Inc, Westlake Village, VA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33468
引用
收藏
页码：AB162 / AB162
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials
    Green, Lawrence J.
    Kerdel, Francisco A.
    Cook-Bolden, Fran E.
    Bagel, Jerry
    Lin, Tina
    Martin, Gina
    Pillai, Radhakrishnan
    Israel, Robert
    Ramakrishna, Tage
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (10) : 1062 - 1069
  • [22] Efficacy and Safety of Once-Daily Luliconazole 1% Cream in Patients ≥12 Years of Age With Interdigital Tinea Pedis: A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Study
    Jarratt, Michael
    Jones, Terry
    Adelglass, Jeffrey
    Bucko, Alicia
    Pollak, Richard
    Roman-Miranda, Amaury
    Olin, Jason T.
    Swinyer, Leonard
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (07) : 838 - 846
  • [23] Safety profile of once-daily 1.5-g granulated mesalamine as maintenance therapy for mild-to-moderate ulcerative colitis: Results from 2 phase 3 trials
    Zakko, Salam
    Murthy, Uma
    Pruitt, Ronald
    Merchant, Kunal
    Shaw, Audrey
    Yuan, James
    Bortey, Enoch
    Forbes, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S437 - S437
  • [24] Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
    Horikawa, Reiko
    Tanaka, Toshiaki
    Hasegawa, Yukihiro
    Yorifuji, Tohru
    Ng, David
    Rosenfeld, Ron G.
    Hoshino, Yuko
    Okayama, Akifumi
    Shima, Daisuke
    Gomez, Roy
    Pastrak, Aleksandra
    Castellanos, Orlando
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (03): : 275 - 285
  • [25] Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
    Gordon, Kenneth B.
    Langley, Richard G.
    Warren, Richard B.
    Okubo, Yukari
    Gold, Linda Stein
    Merola, Joseph F.
    Peterson, Luke
    Wixted, Krista
    Cross, Nancy
    Deherder, Delphine
    Thaci, Diamant
    JAMA DERMATOLOGY, 2022, 158 (07) : 735 - 744
  • [26] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results from the phase 3 DELTA-1 and-2 studies
    Bissonnette, R.
    Worm, M.
    Warren, R. B.
    Agner, T.
    Gooderham, M.
    Schuttelaar, M. L.
    Baranowski, K.
    Plohberger, U.
    Soerensen, L.
    Schliemann, S.
    ALLERGOLOGIE, 2024, 47 (09)
  • [27] Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
    Xue, Mei
    Shen, Pan
    Tang, Jun
    Deng, Xuan
    Dai, Zhe
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year
    Ritchlin, Christopher
    Rahman, Proton
    Helliwell, Philip
    Boehncke, Wolf-Henning
    McInnes, Iain
    Gottlieb, Alice
    Kafka, Shelly
    Kollmeier, Alexa
    Hsia, Elizabeth
    Xu, Xie
    Shawi, May
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Ramachandran, Paraneedharan
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [29] POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR
    Ritchlin, C. T.
    Rahman, P.
    Helliwell, P.
    Boehncke, W. H.
    Mcinnes, I.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1300 - 1301
  • [30] Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II17 - II18
12345